Hamburg, Germany
EVOCAL Health is a pioneering predictive health startup focused on harnessing the power of Vocal Biomarkers & AI. The company aims to revolutionize disease detection and monitoring through the use of voice and smartphones. Leveraging a biopharmaceutical digital health approach, EVOCAL Health develops clinically-proven digital diagnostic and therapeutic concepts that utilize Vocal Biomarkers and AI to prevent, predict, and manage diseases.
Founded in 2020 and based in Germany, EVOCAL Health has quickly gained recognition as one of the fastest growing and most innovative startups in Europe. The company has positioned itself as an innovation leader in digital diagnostics within the Health Care industry, attracting notable attention from the investment community.
Notably, EVOCAL Health secured a Non Equity Assistance investment on 06 October 2021, with funding from PharmStars and Plug and Play Health. This backing underscores the growing interest and confidence from industry leaders in the company's vision and potential to transform healthcare using cutting-edge technology.
With an interdisciplinary and award-winning team, combining expertise in artificial intelligence, machine learning, product management, medicine, engineering, and computer science, EVOCAL Health is well-positioned to lead the next generation of healthcare tools and services.
